Agricultural Farm Products
Compare Stocks
5 / 10Stock Comparison
AVX vs BELFB vs VICR vs CTS vs MCHP
Revenue, margins, valuation, and 5-year total return — side by side.
Hardware, Equipment & Parts
Hardware, Equipment & Parts
Hardware, Equipment & Parts
Semiconductors
AVX vs BELFB vs VICR vs CTS vs MCHP — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Agricultural Farm Products | Hardware, Equipment & Parts | Hardware, Equipment & Parts | Hardware, Equipment & Parts | Semiconductors |
| Market Cap | $213K | $3.67B | $11.79B | $1.71B | $54.97B |
| Revenue (TTM) | $1M | $702M | $453M | $556M | $4.37B |
| Net Income (TTM) | $-19M | $55M | $119M | $69M | $-97M |
| Gross Margin | 38.8% | 39.2% | 57.3% | 38.7% | 51.6% |
| Operating Margin | -10.6% | 15.7% | 18.1% | 15.9% | 4.1% |
| Forward P/E | — | 37.3x | 94.3x | 24.6x | 64.8x |
| Total Debt | $1M | $237M | $13M | $122M | $5.67B |
| Cash & Equiv. | $490K | $58M | $403M | $82M | $772M |
AVX vs BELFB vs VICR vs CTS vs MCHP — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 21 | May 26 | Return |
|---|---|---|---|
| Avax One Technology… (AVX) | 100 | 0.0 | -100.0% |
| Bel Fuse Inc. (BELFB) | 100 | 2129.5 | +2029.5% |
| Vicor Corporation (VICR) | 100 | 226.1 | +126.1% |
| CTS Corporation (CTS) | 100 | 171.1 | +71.1% |
| Microchip Technolog… (MCHP) | 100 | 142.0 | +42.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AVX vs BELFB vs VICR vs CTS vs MCHP
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AVX ranks third and is worth considering specifically for growth.
- 317.0% revenue growth vs MCHP's -42.3%
BELFB is the clearest fit if your priority is growth exposure and valuation efficiency.
- Rev growth 26.3%, EPS growth 42.3%, 3Y rev CAGR 1.1%
- PEG 0.97 vs VICR's 2.10
VICR carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 27.0% 10Y total return vs BELFB's 16.3%
- 26.2% margin vs AVX's -14.4%
- +5.4% vs AVX's -96.9%
- 16.6% ROA vs AVX's -117.7%, ROIC 8.9% vs -98.0%
CTS is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.
- Lower volatility, beta 1.44, Low D/E 22.1%, current ratio 2.30x
- Lower P/E (24.6x vs 64.8x)
- Beta 1.44 vs VICR's 2.79
MCHP is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 5 yrs, beta 1.70, yield 1.8%
- Beta 1.70, yield 1.8%, current ratio 2.59x
- 1.8% yield, 5-year raise streak, vs BELFB's 0.1%, (2 stocks pay no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 317.0% revenue growth vs MCHP's -42.3% | |
| Value | Lower P/E (24.6x vs 64.8x) | |
| Quality / Margins | 26.2% margin vs AVX's -14.4% | |
| Stability / Safety | Beta 1.44 vs VICR's 2.79 | |
| Dividends | 1.8% yield, 5-year raise streak, vs BELFB's 0.1%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +5.4% vs AVX's -96.9% | |
| Efficiency (ROA) | 16.6% ROA vs AVX's -117.7%, ROIC 8.9% vs -98.0% |
AVX vs BELFB vs VICR vs CTS vs MCHP — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
AVX vs BELFB vs VICR vs CTS vs MCHP — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
VICR leads in 2 of 6 categories
CTS leads 1 • MCHP leads 1 • AVX leads 0 • BELFB leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
VICR leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MCHP is the larger business by revenue, generating $4.4B annually — 3241.6x AVX's $1M. VICR is the more profitable business, keeping 26.2% of every revenue dollar as net income compared to AVX's -14.4%. On growth, BELFB holds the edge at +17.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1M | $702M | $453M | $556M | $4.4B |
| EBITDAEarnings before interest/tax | -$13M | $137M | $103M | $123M | $881M |
| Net IncomeAfter-tax profit | -$19M | $55M | $119M | $69M | -$97M |
| Free Cash FlowCash after capex | -$9M | $74M | $119M | $88M | $820M |
| Gross MarginGross profit ÷ Revenue | +38.8% | +39.2% | +57.3% | +38.7% | +51.6% |
| Operating MarginEBIT ÷ Revenue | -10.6% | +15.7% | +18.1% | +15.9% | +4.1% |
| Net MarginNet income ÷ Revenue | -14.4% | +7.8% | +26.2% | +12.4% | -2.2% |
| FCF MarginFCF ÷ Revenue | -6.8% | +10.6% | +26.3% | +15.8% | +18.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +17.2% | +11.5% | +10.9% | +15.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +12.6% | -37.0% | +3.4% | +34.1% | +164.2% |
Valuation Metrics
CTS leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 27.3x trailing earnings, CTS trades at a 73% valuation discount to VICR's 100.1x P/E. Adjusting for growth (PEG ratio), BELFB offers better value at 1.63x vs VICR's 2.23x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $212,616 | $3.7B | $11.8B | $1.7B | $55.0B |
| Enterprise ValueMkt cap + debt − cash | $1M | $3.9B | $11.4B | $1.8B | $59.9B |
| Trailing P/EPrice ÷ TTM EPS | -0.01x | 62.60x | 100.13x | 27.33x | -9999.00x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 37.33x | 94.31x | 24.63x | 64.79x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.63x | 2.23x | 1.75x | — |
| EV / EBITDAEnterprise value multiple | — | 28.67x | 197.81x | 14.68x | 57.21x |
| Price / SalesMarket cap ÷ Revenue | 3.13x | 5.44x | 28.91x | 3.16x | 12.49x |
| Price / BookPrice ÷ Book value/share | 0.03x | 7.02x | 16.50x | 3.23x | 7.71x |
| Price / FCFMarket cap ÷ FCF | — | 54.05x | 98.86x | 19.82x | 71.19x |
Profitability & Efficiency
VICR leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
VICR delivers a 18.7% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $-160 for AVX. VICR carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to MCHP's 0.80x. On the Piotroski fundamental quality scale (0–9), BELFB scores 9/9 vs AVX's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -159.9% | +8.6% | +18.7% | +12.5% | -1.4% |
| ROA (TTM)Return on assets | -117.7% | +5.8% | +16.6% | +8.9% | -0.7% |
| ROICReturn on invested capital | -98.0% | +11.6% | +8.9% | +11.1% | +1.8% |
| ROCEReturn on capital employed | -117.1% | +13.2% | +5.7% | +12.8% | +2.1% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 9 | 7 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.24x | 0.46x | 0.02x | 0.22x | 0.80x |
| Net DebtTotal debt minus cash | $995,040 | $179M | -$390M | $40M | $4.9B |
| Cash & Equiv.Liquid assets | $489,868 | $58M | $403M | $82M | $772M |
| Total DebtShort + long-term debt | $1M | $237M | $13M | $122M | $5.7B |
| Interest CoverageEBIT ÷ Interest expense | -7.20x | 8.38x | — | 18.18x | 0.78x |
Total Returns (Dividends Reinvested)
Evenly matched — BELFB and VICR each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BELFB five years ago would be worth $167,159 today (with dividends reinvested), compared to $0 for AVX. Over the past 12 months, VICR leads with a +535.7% total return vs AVX's -96.9%. The 3-year compound annual growth rate (CAGR) favors BELFB at 89.2% vs AVX's -97.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -67.6% | +68.2% | +123.6% | +36.6% | +56.9% |
| 1-Year ReturnPast 12 months | -96.9% | +314.0% | +535.7% | +53.2% | +115.1% |
| 3-Year ReturnCumulative with dividends | -100.0% | +577.4% | +507.9% | +44.5% | +43.9% |
| 5-Year ReturnCumulative with dividends | -100.0% | +1571.6% | +201.3% | +83.2% | +45.7% |
| 10-Year ReturnCumulative with dividends | -100.0% | +1633.2% | +2704.1% | +253.2% | +373.8% |
| CAGR (3Y)Annualised 3-year return | -97.3% | +89.2% | +82.5% | +13.1% | +12.9% |
Risk & Volatility
Evenly matched — CTS and MCHP each lead in 1 of 2 comparable metrics.
Risk & Volatility
CTS is the less volatile stock with a 1.44 beta — it tends to amplify market swings less than VICR's 2.79 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MCHP currently trades 98.5% from its 52-week high vs AVX's 2.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.35x | 1.88x | 2.79x | 1.44x | 1.70x |
| 52-Week HighHighest price in past year | $19.26 | $307.00 | $293.95 | $60.81 | $103.17 |
| 52-Week LowLowest price in past year | $0.44 | $68.05 | $40.27 | $36.03 | $46.92 |
| % of 52W HighCurrent price vs 52-week peak | +2.7% | +94.6% | +88.9% | +98.4% | +98.5% |
| RSI (14)Momentum oscillator 0–100 | 45.8 | 67.2 | 68.2 | 71.0 | 82.5 |
| Avg Volume (50D)Average daily shares traded | 452K | 179K | 864K | 209K | 9.0M |
Analyst Outlook
MCHP leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BELFB as "Buy", VICR as "Buy", CTS as "Hold", MCHP as "Buy". Consensus price targets imply -3.3% upside for BELFB (target: $281) vs -14.4% for MCHP (target: $87). For income investors, MCHP offers the higher dividend yield at 1.79% vs CTS's 0.27%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | — | $281.00 | $245.00 | — | $87.00 |
| # AnalystsCovering analysts | — | 7 | 7 | 4 | 46 |
| Dividend YieldAnnual dividend ÷ price | — | +0.1% | — | +0.3% | +1.8% |
| Dividend StreakConsecutive years of raises | — | 3 | 0 | 1 | 5 |
| Dividend / ShareAnnual DPS | — | $0.28 | — | $0.16 | $1.82 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.3% | +3.3% | +0.2% |
VICR leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CTS leads in 1 (Valuation Metrics). 2 tied.
AVX vs BELFB vs VICR vs CTS vs MCHP: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AVX or BELFB or VICR or CTS or MCHP a better buy right now?
For growth investors, Avax One Technology Ltd (AVX) is the stronger pick with 317.
0% revenue growth year-over-year, versus -42. 3% for Microchip Technology Incorporated (MCHP). CTS Corporation (CTS) offers the better valuation at 27. 3x trailing P/E (24. 6x forward), making it the more compelling value choice. Analysts rate Bel Fuse Inc. (BELFB) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AVX or BELFB or VICR or CTS or MCHP?
On trailing P/E, CTS Corporation (CTS) is the cheapest at 27.
3x versus Vicor Corporation at 100. 1x. On forward P/E, CTS Corporation is actually cheaper at 24. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Bel Fuse Inc. wins at 0. 97x versus Vicor Corporation's 2. 10x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — AVX or BELFB or VICR or CTS or MCHP?
Over the past 5 years, Bel Fuse Inc.
(BELFB) delivered a total return of +1572%, compared to -100. 0% for Avax One Technology Ltd (AVX). Over 10 years, the gap is even starker: VICR returned +27. 0% versus AVX's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AVX or BELFB or VICR or CTS or MCHP?
By beta (market sensitivity over 5 years), CTS Corporation (CTS) is the lower-risk stock at 1.
44β versus Vicor Corporation's 2. 79β — meaning VICR is approximately 94% more volatile than CTS relative to the S&P 500. On balance sheet safety, Vicor Corporation (VICR) carries a lower debt/equity ratio of 2% versus 80% for Microchip Technology Incorporated — giving it more financial flexibility in a downturn.
05Which is growing faster — AVX or BELFB or VICR or CTS or MCHP?
By revenue growth (latest reported year), Avax One Technology Ltd (AVX) is pulling ahead at 317.
0% versus -42. 3% for Microchip Technology Incorporated (MCHP). On earnings-per-share growth, the picture is similar: Vicor Corporation grew EPS 1764% year-over-year, compared to -100. 1% for Microchip Technology Incorporated. Over a 3-year CAGR, BELFB leads at 1. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AVX or BELFB or VICR or CTS or MCHP?
Vicor Corporation (VICR) is the more profitable company, earning 29.
1% net margin versus -239. 7% for Avax One Technology Ltd — meaning it keeps 29. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BELFB leads at 15. 9% versus -153. 2% for AVX. At the gross margin level — before operating expenses — MCHP leads at 56. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AVX or BELFB or VICR or CTS or MCHP more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Bel Fuse Inc. (BELFB) is the more undervalued stock at a PEG of 0. 97x versus Vicor Corporation's 2. 10x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, CTS Corporation (CTS) trades at 24. 6x forward P/E versus 94. 3x for Vicor Corporation — 69. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BELFB: -3. 3% to $281. 00.
08Which pays a better dividend — AVX or BELFB or VICR or CTS or MCHP?
In this comparison, MCHP (1.
8% yield), CTS (0. 3% yield) pay a dividend. AVX, BELFB, VICR do not pay a meaningful dividend and should not be held primarily for income.
09Is AVX or BELFB or VICR or CTS or MCHP better for a retirement portfolio?
For long-horizon retirement investors, Bel Fuse Inc.
(BELFB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1633% 10Y return). Avax One Technology Ltd (AVX) carries a higher beta of 2. 35 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BELFB: +1633%, AVX: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AVX and BELFB and VICR and CTS and MCHP?
These companies operate in different sectors (AVX (Consumer Defensive) and BELFB (Technology) and VICR (Technology) and CTS (Technology) and MCHP (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: AVX is a small-cap high-growth stock; BELFB is a small-cap high-growth stock; VICR is a mid-cap quality compounder stock; CTS is a small-cap quality compounder stock; MCHP is a mid-cap quality compounder stock. MCHP pays a dividend while AVX, BELFB, VICR, CTS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.